CRINETICS PHARMACEUTICALS INC (CRNX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CRNX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CRNX | ["Senior Executive Leadership","Regulatory & Compliance","Global Market Access & Commercialization","Corporate Strategy & Business Development","Finance & Capital Markets","Human Capital Management & Succession"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VTRS | Founder and Chief Executive Officer | 62 | ["CEO and Public Company Management", "Corporate Governance", "Finance", "Accounting", "Capital Markets", "Healthcare Industry", "Risk Oversight/Compliance", "Strategy and M&A Experience"] | ["Compliance and Risk Oversight", "Science and Technology"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Vivaldi has a 30 plus year career specializing in rare diseases, with deep expertise in global commercial operations, market access, and patient advocacy. His leadership in launching global therapies and building commercial franchises provides the Board with essential insights into the commercialization phase of drug development. Career Highlights President and CEO, Sigilon Therapeutics, Inc. (2018 2023) Executive VP and Chief Global Therapeutics Officer, Bioverativ Inc. (2016 2018; acquired by Sanofi) Chief Commercial Officer, Spark Therapeutics, Inc. (2014 2016) Various Leadership Roles, Genzyme (20 years), including Head of Rare Disease Business and President of Renal & Endocrine Group. Dr. Vivaldi holds an M.D. from the Federal University of Rio de Janeiro.